Compounds useful for inhibiting Chk1

Details for Australian Patent Application No. 2009333433 (hide)

Owner Eli Lilly and Company

Inventors Farouz, Francine S.; Holcomb, Ryan Coatsworth; Kasar, Ramesh; Myers, Steven Scott

Agent Spruson & Ferguson

Pub. Number AU-B-2009333433

PCT Pub. Number WO2010/077758

Priority 61/138,176 17.12.08 US

Filing date 10 December 2009

Wipo publication date 8 July 2010

Acceptance publication date 14 June 2012

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/497 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/077758 Priority application(s): WO2010/077758

14 June 2012 Application Accepted

  Published as AU-B-2009333433

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333437-Identifying a self-powered device connected to a medical device

2009333429-Optically active functional fluid markers